DP
David Paul Kenny
About David Paul Kenny
Data last updated:
David Paul Kenny is a Director at Veeda Clinical Research Limited (since 2024). The company operates in Pharma. Veeda Clinical Research Limited reported revenue of ₹621 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Veeda Clinical Research Limited U73100GJ2004PLC044023 | Director | 11 Dec 2024 | 2004 | ₹621 Cr (FY 2025) | Active |
Board colleagues of David Paul Kenny
Directorship timeline
Open interactive timeline →Shareholding and investment profile for David Paul Kenny
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about David Paul Kenny
David Paul Kenny currently holds 1 directorship: Veeda Clinical Research Limited (Director, since 11 Dec 2024, revenue ₹621 Cr (FY 2025)).
David Paul Kenny was first appointed on 11 Dec 2024 as Director at Veeda Clinical Research Limited.
The current boards of David Paul Kenny's companies include Apurva Bhupendra Shah (Veeda Clinical Research Limited), Binoy Hasmukh Gardi (Veeda Clinical Research Limited), Binoy Hasmukh Gardi (Veeda Clinical Research Limited), Georgios Kouvatseas (Veeda Clinical Research Limited), Ioannis Orfanidis (Veeda Clinical Research Limited), Jeanne Taylor Hecht (Veeda Clinical Research Limited), among others.